AMD vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

AMD

53.5
AI Score
VS
AMD Wins

MRNA

39.9
AI Score

Investment Advisor Scores

AMD

54score
Recommendation
HOLD

MRNA

40score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AMD MRNA Winner
Revenue 21.79B 534.00M AMD
Net Income 3.68B -2.13B AMD
Net Margin 16.9% -397.9% AMD
Operating Income 3.47B -2.20B AMD
ROE 5.5% -31.4% AMD
ROA 4.4% -19.4% AMD
Total Assets 84.46B 10.96B AMD
Cash 5.09B 1.72B AMD
Debt/Equity 0.03 0.09 AMD
Current Ratio 2.61 2.29 AMD
Free Cash Flow 4.12B -1.25B AMD

Relative Price Performance (Last 90 Days)

AMD 1M: +27.7% · 3M: +18.1% MRNA 1M: +40.0% · 3M: +156.6%

Current Technical Phase

AMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 70

RSI (14): 70.4 · Price: $645.86

MRNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (49.6% over 20 days), RSI 64

RSI (14): 63.6 · Price: $196.48

Fundamentals Snapshot

Metric AMD MRNA
Market Cap — —
Forward P/E 41.1 -41.0
Trailing P/E 165.7 —
Revenue (TTM) — —
Revenue Growth 0.5% 0.0%
Gross Margin 0.6% -0.7%
Operating Margin 0.2% -5.6%
EPS 3.92 -7.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AMD is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.